HIV therapy and prevention: economics and cost-effectiveness.
Moore
R
R
D017088:AIDS-Related Opportunistic Infections / Q000191:economics / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D008484:Medicaid; D014481:United States
D019380:Anti-HIV Agents